JOHN·INVESTMENTS
PREPARING00
HomeMarketsIlliquid Securities

Illiquid Securities
Solutions

We provide institutional access and structured evaluation support for securities that are no longer actively traded, have limited market liquidity, or have become difficult to transfer through conventional exchange mechanisms.

Illiquid securities analysis
OVERVIEW

Illiquid securities represent financial instruments that have lost active market liquidity or are no longer efficiently tradable through standard exchange channels. This may occur due to delisting events, trading suspensions, corporate restructurings, regulatory changes, or prolonged inactivity in secondary markets.

While such securities are often perceived as inactive or non-performing from a market perspective, they remain legally valid ownership interests in the underlying issuing entity. In many cases, they may still represent exposure to corporate assets, restructuring outcomes, litigation recoveries, or future strategic transactions.

Our role is to evaluate these positions within a structured institutional framework and identify whether any potential recovery pathways, secondary market interest, or strategic transaction opportunities may exist.

DEFINITION

What Are Illiquid Securities?

Illiquid securities are financial instruments that cannot be easily sold or transferred without significant delay, discounting, or reliance on specialized transaction channels. These situations typically arise when:

  • A company has been delisted from a public exchange
  • Trading has been suspended or halted
  • Market makers no longer provide active quotes
  • The security trades on OTC or restricted platforms with minimal volume
  • The issuer is undergoing restructuring or insolvency proceedings
  • Regulatory or compliance restrictions limit market participation

In such circumstances, traditional price discovery mechanisms may no longer function effectively, leading to uncertainty around valuation and liquidity.

However, illiquidity does not automatically imply a lack of underlying value. It indicates that conventional trading infrastructure is no longer functioning for that specific instrument.

TYPES WITHIN OUR SCOPE

Asset Types Within Our Scope

We evaluate a broad range of illiquid financial instruments across multiple jurisdictions and market environments.

01

Delisted Securities

Equity instruments that have been removed from a regulated exchange but continue to exist as legal ownership interests.

02

Suspended Securities

Securities subject to temporary or extended trading suspension due to regulatory, financial or corporate events.

03

Over-the-Counter Securities

Instruments traded on OTC markets with limited liquidity, pricing transparency or institutional participation.

04

Restricted Securities

Holdings subject to contractual, regulatory or transfer limitations that reduce marketability.

05

Legacy Equity Positions

Long-term holdings in companies that no longer maintain active market presence or investor coverage.

06

Cross-Border Securities

Foreign-issued instruments with limited accessibility or fragmented secondary market infrastructure.

CAUSES

Why Illiquidity Occurs

Illiquidity in securities markets typically results from structural, regulatory or corporate developments rather than a single isolated cause. Common drivers include:

Corporate Events

Delistings, mergers, acquisitions, restructurings or bankruptcies.

Market Structure Changes

Loss of exchange listing, reduced analyst coverage or withdrawal of market makers.

Regulatory Factors

Compliance issues, reporting failures or jurisdictional restrictions.

Investor Base Contraction

Declining institutional participation or retail investor disengagement.

Operational Limitations

Transfer restrictions, custody issues or settlement inefficiencies.

Underlying Value Persists

Each factor affects market accessibility but does not necessarily eliminate underlying asset value.

OUR APPROACH

Institutional Review Framework

Our approach to illiquid securities is based on structured analysis, documentation review and identification of potential transaction pathways.

01

Initial Assessment

Review of available security information, issuer details and market status.

02

Documentation Review

Analysis of custody records, shareholder statements and relevant corporate documentation.

03

Corporate Status Analysis

Evaluation of issuer condition, including restructuring activity, insolvency proceedings or strategic developments.

04

Marketability Assessment

Assessment of whether secondary market interest or institutional demand may exist.

05

Counterparty Mapping

Identification of potential investors, special situations funds or strategic acquirers.

06

Transaction Feasibility Review

Evaluation of possible transfer structures and execution pathways.

PATHWAYS

Potential Transaction Pathways

Depending on the nature of the asset, illiquid securities may be addressed through several potential structures.

Secondary Market Transfer

Direct sale between existing holder and qualified counterparty.

Block Position Acquisition

Aggregation of multiple holdings into a larger transferable position.

Restructuring Participation

Involvement in corporate restructuring or recapitalization processes.

Claims Conversion

In certain insolvency contexts, securities may be converted into claims or recovery instruments.

Strategic Acquisition

Purchase of securities as part of broader corporate or asset-level transactions.

Subject to Conditions

Each pathway is subject to legal, regulatory and counterparty considerations.

INSTITUTIONAL INTEREST

Who Acquires Illiquid Securities

Illiquid securities are primarily of interest to specialized market participants who focus on complex, distressed or non-standard asset classes. Typical counterparties include:

Special Situations Funds Distressed Asset Investors Alternative-Strategy Hedge Funds Private Equity Firms Strategic Corporate Acquirers Long-Horizon Family Offices

These investors typically evaluate illiquid securities based on underlying asset value, restructuring potential or strategic positioning rather than short-term market pricing.

KEY CONSIDERATIONS

Key Considerations

Transacting illiquid securities involves specific considerations that differ significantly from traditional equity markets. These may include:

  • Limited pricing transparency
  • Extended transaction timelines
  • Jurisdictional complexity
  • Transfer restrictions
  • Corporate restructuring risk
  • Legal and documentation requirements

Accordingly, each situation requires independent evaluation and cannot be generalized based on market benchmarks alone.

FREQUENTLY ASKED QUESTIONS

Frequently Asked Questions

Do illiquid securities still have value?

In some cases, illiquid securities may retain value depending on issuer circumstances, underlying assets, restructuring outcomes or potential strategic transactions. However, no outcome is guaranteed and each case must be assessed individually.

Can illiquid securities be sold?

Yes, but typically only through specialized secondary market channels or direct transactions with qualified counterparties. Liquidity is not guaranteed and may require extended execution timeframes.

Do you guarantee buyers for illiquid securities?

No. Any potential transaction depends on counterparty interest, due diligence outcomes and prevailing market conditions.

What types of investors buy illiquid securities?

Typically institutional investors, special situations funds, hedge funds, private equity firms and strategic acquirers.

Is this service regulated financial advice?

No content on this page constitutes financial, legal or investment advice. All activities are subject to applicable regulatory requirements.

CONFIDENTIAL REVIEW

Submit Your Illiquid Security
for Confidential Review

If you hold securities that are no longer actively traded, have been delisted, or are otherwise difficult to transfer through conventional markets, our team can conduct a confidential preliminary assessment.

Submission does not guarantee valuation, liquidity or transaction execution. Each case is reviewed independently based on available information and market conditions.